Same Indication

Lisinopril vs Upadacitinib

Lisinopril vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Lisinopril and Upadacitinib.

Mechanism of Action

Lisinopril: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Lisinopril β€” 12 hours; Upadacitinib β€” 9-14 hours.

Chemical Properties

Molecular Formula: Lisinopril β€” C21H31N3O5; Upadacitinib β€” C17H19F3N6O.

Molecular Weight: Lisinopril β€” 405.4900 g/mol; Upadacitinib β€” 380.3700 g/mol.

Type: Lisinopril β€” Small molecule; Upadacitinib β€” Small molecule.